Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Rio Man Becomes First Brazilian to Test Potential AIDS Vaccine

From U.S. Centers for Disease Control and Prevention

November 6, 2001

A 38-year-old man was injected with an experimental AIDS vaccine Monday, becoming the first Brazilian to take part in clinical trials of two potential vaccines already being tested in the United States. The US National Institutes of Health is sponsoring the Brazil study in conjunction with the Federal University of Rio de Janeiro. The trials involve the ALVAC-HIV vCP1452 vaccine, developed by Aventis Pasteur, and the MNrgp120 vaccine, developed by VaxGen. Both vaccines have been found to induce immune reaction in the United States where 300 people have been injected, said the project's Brazil organizer Dr. Mauro Schechter. "We're testing them simultaneously here, in Trinidad and in Haiti," said Schechter. Doctors eventually plan to vaccinate 40 people in Brazil, but Schechter says he has only 10 volunteers so far.


Back to other CDC news for November 6, 2001

Previous Updates

Adapted from:
Associated Press
11.05.01; Michael Astor

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
 

Advertisement